Switching medical devices sourcing from Japan to Netherlands

Sourcing medical devices is now a tariff decision as much as a supplier decision. Goods from Japan clear at an effective 16.5%, while Netherlands clears the same category at 11.5% — about $5,275 a year at $100,000 of imports. Two suppliers can quote the same factory price and still land at very different costs once Customs is done. The breakdown below itemises both duty stacks so the figure is auditable, not asserted.

How the tariff stacks compare

Here is how US Customs builds the bill for each origin. Sourced from Japan, the goods face a 1.5% Most-Favoured-Nation base duty and a 15% negotiated bilateral rate on its medical devices, an effective 16.5% once the $49.74 in processing fees are added. From Netherlands, the entry is assessed a 1.5% Most-Favoured-Nation base duty and a 10% Section 122 reciprocal surcharge on its medical devices, an effective 11.5% once the $49.74 in processing fees are added. Section 122 adds a reciprocal duty that one origin escapes via a bilateral deal — a meaningful but expiring factor in the current gap. Because the MPF and HMF ($49.74 combined) track customs value rather than origin, they wash out of the comparison entirely. The arithmetic difference between the stacks is $527.50 per $10,000 entry, all of it in the duty layers since the processing fees are origin-blind. That same per-dollar gap is about $1,319 on a $25,000 order and $5,275 on $100,000 of annual volume. Per $25,000 order, $1,319 separates the two origins — small per shipment, compounding fast across a program.

Trade context

medical devices — MRI machines, Ultrasound equipment, Surgical instruments, and Orthopedic implants and similar goods — falls under HTS 9018, 9019, 9020, 9021. Medical Devices is a high-turnover category where landed-cost discipline separates the importers who hold margin from those who don't. Japan, in Asia-Pacific, ships the US mainly passenger vehicles, auto parts components, and industrial machinery. Japan trades under a bilateral arrangement that replaces the reciprocal surcharge with a fixed rate on medical devices. Netherlands, in Europe, ships the US mainly industrial machinery, chemicals industrial compounds, and consumer electronics. Netherlands trades under the EU bilateral framework, which shapes the duties on its medical devices. Moving between Asia-Pacific and Europe changes more than duty, so treat the tariff saving as one input among several. Netherlands clears this category at a structurally lower rate than Japan, an edge that persists across order cycles rather than a spot-price blip. With the US running its highest average tariff in decades, concentrated exposure to one high-duty origin is now a measurable annual cost rather than an abstract risk.

Recommendation

Anchor your own volume to these tiers: $2,638 at $50,000, $13,188 at $250,000, $52,750 at $1,000,000, and about $5,275 at $100,000. Every figure is produced by the same tariff engine behind the site's calculators, holding FOB value, freight and insurance constant so only the duty effect of origin shows through. These figures reflect tariff and fee savings only, assuming equal product cost — your actual landed cost also depends on price and freight, which vary by supplier. Read the $5,275 as a transition budget — if re-sourcing to Netherlands costs less than the annual saving, it pays back inside a year. Diligence on Netherlands is commercial, not regulatory: supplier capacity, MOQ, tooling and re-qualification cost — the duty advantage itself is already settled above. Lock the comparison to a quote date; a surcharge added or lifted can change the ranking between negotiation and purchase order. Use the Tariff Savings Finder to test your real numbers and see alternatives beyond Netherlands. One origin still carries the Section 122 surcharge, due to expire mid-2026; the ranking can shift once it lapses.